학술논문

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
Document Type
Article
Source
In Annals of Oncology November 2019 30 Supplement 8
Subject
Language
ISSN
0923-7534